SCHEMBL309125

SCHEMBL309125

Brc1ccc(-c2nc3ccccc3o2)cc1

nearest known ligand 0.71

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.69
RAB9A P51151 5/20 0.69
MEN1 O00255 2/20 0.69
KMT2A Q03164 2/20 0.69
ATM Q13315 1/20 0.69
ALDH1A1 P00352 3/20 0.63
HSD17B10 Q99714 3/20 0.63
KDM4E B2RXH2 2/20 0.63
HPGD P15428 2/20 0.63
SMN1; SMN2 Q16637 2/20 0.63
TP53 P04637 1/20 0.63
RXFP1 Q9HBX9 1/20 0.61
MMP2 P08253 1/20 0.59
MMP9 P14780 1/20 0.59
MMP8 P22894 1/20 0.59
MMP13 P45452 1/20 0.59
MAPT P10636 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23303865 1.00 NPC1 (0.69) NPC1RAB9AMEN1KMT2AATM
SCHEMBL19270479 0.98 NPC1 (0.67) NPC1RAB9AMEN1KMT2AATM
SCHEMBL25546320 0.91 NPC1 (0.58) NPC1RAB9AMEN1KMT2AATM
SCHEMBL31170 0.90 NPC1 (0.81) NPC1RAB9AMEN1KMT2AATM
Methane SCHEMBL29265168 0.88 NPC1 (0.79) NPC1RAB9AMEN1KMT2AATM
SCHEMBL31476 0.88 NPC1 (0.79) NPC1RAB9AMEN1KMT2AATM
SCHEMBL27423396 0.87 NPC1 (0.54) NPC1RAB9AMEN1KMT2AATM
SCHEMBL29392949 0.86 NPC1 (0.61) NPC1RAB9AMEN1KMT2AATM
SCHEMBL24332269 0.86 NPC1 (0.61) NPC1RAB9AMEN1KMT2AATM
SCHEMBL19846155 0.85 KDM4E (0.57) NPC1RAB9AMEN1KMT2AATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 370 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114933595-B 2-Phenylbenzoxazole multi-stimulus response fluorescent material and preparation method thereof 长春工业大学 2024-04-30 CN claimed
CN-117736158-A Method for efficiently synthesizing 4- (benzo [ D ] oxazol-2-yl) -N-phenylaniline 中唯炼焦技术国家工程研究中心有限责任公司 2024-03-22 CN claimed
CN-114436971-A Di (4- (benzoxazol-2-yl) phenyl) methylamine derivative and preparation method thereof 陕西维世诺新材料有限公司 2022-05-06 CN claimed
CN-107501988-B Preparation method of solvent red 195 宁波德欣科技有限公司 2020-09-25 CN claimed
CN-110283137-A A kind of preparation method of 2- (4- bromophenyl) -1,3- benzoxazoles 爱斯特(成都)生物制药股份有限公司 2019-09-27 CN claimed
CN-107501988-A A kind of preparation method of solvent red 195 宁波德欣科技有限公司 2017-12-22 CN claimed
EP-4131456-B1 ORGANIC LIGHT-EMITTING DEVICE SFC CO LTD (KR) 2026-02-18 EP disclosed
EP-4678632-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP AGC Inc. (JP) 2026-01-14 EP disclosed
US-20250386668-A1 AMINE COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE, ELECTRONIC APPARATUS, AND ELECTRONIC DEVICE INCLUDING THE SAME HODOGAYA CHEMICAL CO., LTD. (JP) 2025-12-18 US disclosed
US-20250346557-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP AGC Inc. (JP) 2025-11-13 US disclosed
WO-2025121699-A1 HETEROARYL AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 주식회사 랩토 2025-06-12 WO disclosed
CN-114946273-B Organic electroluminescent element 保土谷化学工业株式会社 2025-06-03 CN disclosed
EP-4553074-A1 AMINE COMPOUND, AND ORGANIC ELECTROLUMINESCENCE ELEMENT, ELECTRONIC EQUIPMENT, AND ELECTRONIC ELEMENT CONTAINING SAME Hodogaya Chemical Co., Ltd. (JP) 2025-05-14 EP disclosed
WO-2007088148-A1 DERIVATIVES OF THIOPHENE CARBOXILIC ACID AS ANTIVIRAL AGENT SMITHKLINE BEECHAM CORPORATION (US) 2007-08-09 WO disclosed
WO-2007071434-A1 ANTIVIRAL 2-CARBOXY-THIOPHENE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 2007-06-28 WO disclosed
WO-2007039146-A1 4-CARBOXY PYRAZOLE DERIVATIVES AS ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2007-04-12 WO disclosed
WO-2007039146-A1 4-CARBOXY PYRAZOLE DERIVATIVES AS ANTI-VIRAL AGENTS SMITHKLINE BEECHAM CORPORATION (US) 2007-04-12 WO disclosed
EP-0674635-B1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS SYNGENTA LTD (GB) 2001-03-28 EP disclosed
EP-0674635-A1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS ZENECA LIMITED (GB) 1995-10-04 EP disclosed
WO-1994014803-A1 QUINUCLIDINE DERIVATIVES AS SQUALENE SYNTHASE INHIBITORS ZENECA LIMITED (GB) 1994-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250346557-A1 METHOD FOR PRODUCING ARYL COMPOUND CONTAINING TRITYLSULFANYL GROUP STS, TST, CYP3A5 NPC1 1421/4885RAB9A 2586/4885MEN1 2406/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.